Stocks

Prothena Corp Public PRTA

Health care sectorNasdaq

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Dublin 2
Fiscal year end
12/31
Next earnings
11/05, estimated

No member of Congress reported a trade in Prothena Corp Public PRTA in the past 90 days. Insiders filed 2 purchases and 0 sales on the open market over the same period, a net purchase of $2.3M.

Korean holdings rank
Outside the top 50
Korea Securities Depository · released 09/22
Congress trades
No record
Last 90 days · 0 buys · 0 sales
Insider net buying
+$2.3M
Last 90 days · bought $2.3M · sold $0
Next earnings
11/05
Estimated from the last four quarters

26-week trading

Common questions

Did Prothena Corp Public PRTA insiders buy or sell in the past 90 days?
In the past 90 days insiders filed 2 purchases and 0 sales on the open market. Purchases came to $2.3M.